CompletedNot Applicable

RSV Antibiotic Drivers And Resource-use

Turkey (Türkiye)209 participantsStarted 2017-04-01

Plain-language summary

This study retrospectively evaluated the clinical, laboratory, and radiologic factors that influence the decision to prescribe antibiotics in children under 2 years of age hospitalized with RSV-positive acute lower respiratory tract infections. The study also examined the economic impact of antibiotic use in these patients. The goal is to improve clinical decision-making and reduce unnecessary antibiotic exposure in children with viral infections.

Who can participate

Age range1 Month – 24 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age between 1 and 24 months at the time of hospitalization * Laboratory-confirmed RSV positivity via multiplex PCR * Hospitalized for acute lower respiratory tract infection * Complete hospitalization and clinical data available Exclusion Criteria: * Detection of additional respiratory pathogens on multiplex PCR * Discharge against medical advice before treatment was completed * Missing or incomplete key clinical, laboratory, or radiologic data * ICU admission without full follow-up data

What they're measuring

Association between clinical/laboratory/radiologic parameters and antibiotic prescription

Timeframe: During hospitalization (April 2017 - April 2021)

Trial details

NCT IDNCT06977971

SponsorDr. Behcet Uz Children's Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-04-01

View on ClinicalTrials.gov More Respiratory Syncytial Virus Infections trials